Targeting GIPC/Synectin in Pancreatic Cancer Inhibits Tumor Growth

TRANSLATIONAL RELEVANCE: The five year survival rate in patients with ductal adenocarcinoma of the pancreas is less than 4%. Accordingly, new targets for the treatment of this deadly disease are urgently needed. In this study, we show that targeting GAIP interacting protein C-terminal (GIPC, also kn...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Muders, Michael H., Vohra, Pawan K., Dutta, Shamit K, Wang, Enfeng, Ikeda, Yasuhiro, Wang, Ling, Udugamasooriya, D. Gomika, Memic, Adnan, Rupashinghe, Chamila N., Baretton, Gustavo B., Aust, Daniela E., Langer, Silke, Datta, Kaustubh, Simons, Michael, Spaller, Mark R., Mukhopadhyay, Debabrata
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2731998/
https://ncbi.nlm.nih.gov/pubmed/19509165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-2837
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados